Get the Stockscreener App
4.30
2.49%
-0.11
After Hours:
4.25
-0.05
-1.16%
Hcw Biologics Inc stock is traded at $4.30, with a volume of 16,214.
It is down -2.49% in the last 24 hours and down -4.44% over the past month.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
See More
Previous Close:
$4.41
Open:
$4.29
24h Volume:
16,214
Relative Volume:
0.02
Market Cap:
$6.19M
Revenue:
$3.50M
Net Income/Loss:
$-37.33M
P/E Ratio:
-4.30
EPS:
-1
Net Cash Flow:
$-19.15M
1W Performance:
-2.71%
1M Performance:
-4.44%
6M Performance:
-60.88%
1Y Performance:
-82.66%
1-Day Range:
$4.1241
$4.41
1-Week Range:
$4.02
$4.44
52-Week Range:
$3.55
$100.80
Hcw Biologics Inc Stock (HCWB) Company Profile
Name
Hcw Biologics Inc
Sector
Industry
Phone
954-842-2024
Address
2929 N COMMERCE PKWY, MIRAMAR
Compare HCWB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
4.30 | 11.19M | 3.50M | -37.33M | -19.15M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Hcw Biologics Inc Stock (HCWB) Latest News
Using data filters to optimize entry into HCW Biologics Inc.Daily Equity Signal Strength Summary Report - Newser
HCW Biologics Inc. Recovery Hinges on Volume BreakoutFast Return Equity Trade Forecast Points to Small Caps - metal.it
MACD Cross Could Confirm Trend in HCW Biologics Inc.Smart Allocation Stock Pick Insights Gaining Interest - metal.it
Is HCW Biologics Inc. showing signs of accumulationFree Low Risk Buy Zone Opportunity Watch - Newser
Will HCW Biologics Inc. price bounce be sustainableAI Screener for Daily Stock Forecast - Newser
Will HCW Biologics Inc. stock benefit from interest rate changesLow Exposure Strategy with Sector Analysis - Newser
What makes HCW Biologics Inc. stock price move sharplyFree Early Breakout Entry Point Notifications - Newser
Why HCW Biologics Inc. stock attracts strong analyst attentionSummary of Trade Cycles in 5-Year Range - Newser
When is HCW Biologics Inc. stock expected to show significant growthMarket Forecast Target Finder For 2025 - jammulinksnews.com
What is HCW Biologics Inc. company’s growth strategyAchieve consistent profits with expert advice - jammulinksnews.com
Is HCW Biologics Inc. a growth stock or a value stockDiscover high-impact stocks for growth - jammulinksnews.com
Is it the right time to buy HCW Biologics Inc. stockSuperior capital gains - jammulinksnews.com
Has HCW Biologics Inc. Stock Ever Crashed Historical Volatility ReviewFree Membership Group - Newser
Is HCW Biologics Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree Stock Investment Discussion Area - Newser
How Resilient Is HCW Biologics Inc. Stock During Economic DownturnsFree Stock Market Expert Consultation - Newser
Is HCW Biologics Inc. stock a growth or value playFree Stock Market Trend Analysis - jammulinksnews.com
What drives HCW Biologics Inc. stock priceFree Stock Market Query - Autocar Professional
HCW Biologics Inc. Stock Analysis and ForecastHigh-octane financial growth - Autocar Professional
Is HCW Biologics Inc. a good long term investmentUnprecedented growth rates - PrintWeekIndia
What analysts say about HCW Biologics Inc. stockSky-high return potential - Autocar Professional
HCW Biologics : July 2025 - MarketScreener
HCW Biologics Soars 9.78% on Pipeline Advancements - AInvest
Hcw Biologics Inc Stock (HCWB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):